USPTO Examiner BOECKELMAN JACOB A - Art Unit 1655

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18972246TRADITIONAL CHINESE HERBAL COMPOSITION FOR TREATMENT OF BACTERIAL VAGINOSIS AND PREPARATION METHOD THEREOFDecember 2024February 2025Allow200NoNo
18467250TRADITIONAL CHINESE MEDICINE OINTMENT FOR PREVENTING AND TREATING MASTITIS IN DAIRY COWS, AND PREPARATION METHOD THEREOFSeptember 2023November 2024Allow1421NoNo
18141249Production of Ethanol-free Vanilla ExtractsApril 2023February 2025Allow2111YesNo
18307570BEETROOT-CONTAINING COMPOSITIONApril 2023March 2024Allow1101YesNo
18129647METHOD AND COMPOSITION FOR PRODUCTION OF A PHYTONUTRIENT IN A MICROBIOMEMarch 2023January 2025Abandon2111NoNo
18126519COMPOSITIONS COMPRISING FUCOXANTHIN AND USE THEREOF IN REDUCTION OF FAT ACCUMULATION IN CELLSMarch 2023May 2025Abandon2510NoNo
18156431HERBAL COMPOSITION FOR TREATMENT OF ACIDITY AND INDIGESTION PROBLEMJanuary 2023July 2024Abandon1811NoNo
18089896COMPOSITIONS COMPRISING THEANINE, MAGNOLIA, AND PHELLODENDRONDecember 2022June 2024Allow1802YesNo
18073535REPELLANT FORMULATION AND METHODDecember 2022March 2025Allow2820YesNo
18073538REPELLANT FORMULATION AND METHODDecember 2022March 2025Allow2820YesNo
17966912PROCESS FOR PRESERVING THE HUSK AND USE OF RAMBUTAN (NEPHELIUM LAPPACEUM) IN FOOD PRODUCTSOctober 2022April 2024Abandon1810NoNo
17966924PROCESS FOR PRESERVING THE HUSK AND USE OF RAMBUTAN (NEPHELIUM LAPPACEUM) IN FOOD PRODUCTSOctober 2022July 2024Abandon2110NoNo
17963888PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING GYNECOLOGICAL DISEASES CONTAINING SARCODON ASPRATUS EXTRACTS AS ACTIVE INGREDIENTOctober 2022September 2023Allow1100NoNo
17960503USE OF POLYPHENOL CONTAINING SUGAR CANE EXTRACTS FOR PREVENTING, IMPROVING OR TREATING A SKIN CONDITIONOctober 2022March 2025Allow3031NoNo
17947012TOPICAL COMPOSITIONS FOR ENHANCING A MAN'S SEXUAL RESPONSIVENESS AND PERFORMANCESeptember 2022June 2024Abandon2101NoNo
17898017METHODS FOR ENHANCING SLEEP QUALITYAugust 2022August 2024Abandon2330NoNo
17819705BOTANICAL ANTIVIRAL NUTRITIONAL SUPPLEMENTAugust 2022July 2024Abandon2311NoNo
17885579TRADITIONAL CHINESE MEDICINE EYE DROPS AND THE PREPARATION METHOD THEREOFAugust 2022April 2024Allow2011YesNo
17759122PLANT-BASED COMPOSITION IN A FORM SUITABLE FOR TOPICAL ADMINISTRATION AND ASSOCIATED PRODUCTION METHODJuly 2022May 2025Abandon3401NoNo
17868704COMPOSITION FOR ENHANCING IMMUNITY OR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES BY USING GOJI BERRIES, MULBERRIES AND JUJUBESJuly 2022July 2023Allow1211YesNo
17859028TRADITIONAL CHINESE MEDICINE COMPOUND COMPOSITION WITH EFFECT OF IMPROVING MALE SEXUAL FUNCTION AND APPLICATION THEREOFJuly 2022July 2024Abandon2420NoNo
17860079TIBETAN FOUR-INGREDIENT LUNG-CLEARING MIXTURE AND APPLICATION THEREOF IN PREPARING MEDICATION FOR TREATING RESPIRATORY DISEASESJuly 2022January 2025Abandon3120NoNo
17856956Hepatoprotective Effects of Palauan Folk MedicineJuly 2022July 2024Abandon2420YesNo
17779680COMPOSITION FOR PREVENTING OR TREATING HYPERTENSIONMay 2022April 2025Allow3511NoNo
17725587Honey FoamApril 2022March 2024Abandon2301NoNo
17770048PROCESS FOR THE PRODUCTION OF TAMARIND EXTRACTApril 2022June 2025Abandon3710NoNo
17721908COMPOSITION OF MATTER AND METHODS FOR A FECAL-DERIVED STERILIZED PREBIOTIC AND POSTBIOTICApril 2022March 2025Allow3851YesNo
17767604Composition For Preventing Or Treating Neurodegenerative Diseases Containing Mixed Herbal Extract Of Genkwae Flos, Clematidis Radix, And Gastrodiae RhizomaApril 2022May 2025Abandon3710NoNo
17706270HEALTH BENEFITING COMPOSITIONS OF DAILY NUTRITION AND METHODS OF USE THEREOFMarch 2022February 2024Allow2321NoNo
17640677THERAPEUTIC AGENT FOR MYOCARDITISMarch 2022June 2025Abandon3910NoNo
17637915COMPOSITION FOR AMELIORATING PREMENSTRUAL SYNDROME SYMPTOMS, INCLUDING CHRYSANTHEMUM ZAWADSKII EXTRACTFebruary 2022October 2024Allow3230YesNo
17588211SYSTEMS AND METHODS FOR PRODUCING A KAVA LIQUID DIETARY SUPPLEMENTJanuary 2022April 2025Abandon3801NoNo
17587535TREATMENT OF AGING OR UV-DAMAGED SKINJanuary 2022March 2025Abandon3801NoNo
17631320PREPARATION COMPRISING OMEGA-3 FATTY ACID SALTS AND EXTRACTS OF GUM RESINS FROM BOSWELLIA SPECIESJanuary 2022January 2025Allow3510YesNo
17585612METHOD FOR IMPROVING BODY SHAPE AND IMPROVING SKIN CONDITION USING NONI FRUIT FERMENTJanuary 2022September 2023Allow2011NoNo
17568390NUTRITION-BASED METHOD FOR MANAGING ANIMAL BEHAVIORJanuary 2022January 2024Abandon2511YesNo
17560772USE OF GINSENG ALCOHOL EXTRACT IN SLEEP-PROMOTING HEALTH CARE PRODUCTS OR FOODSDecember 2021January 2024Allow2421YesNo
17557250Oral Cannabis Substance and Method of Making Such SubstanceDecember 2021January 2024Abandon2510NoNo
17555028TONGKAT ALI EXTRACT PRODUCTION PROCESSES AND USES THEREOFDecember 2021December 2022Abandon1110NoNo
17619617METHOD FOR EXTRACTION OF A RAW MATERIAL TO PRODUCE A FORMULATION RICH IN PHYTOCHEMICALSDecember 2021May 2025Abandon4110NoNo
17553503PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD FOR PREVENTING, AMELIORATING OR TREATING DIABETES CONTAINING WASP EXTRACT AS ACTIVE INGREDIENTDecember 2021February 2024Abandon2610NoNo
17545768COMPOSITIONS HAVING THE ABILITY TO PROMOTE HEALTHY CHOLESTEROL LEVELSDecember 2021August 2023Abandon2001NoNo
17457937METHOD FOR EXTRACTION OF AN AGENT FROM A PLANT SOURCEDecember 2021February 2025Abandon3801NoNo
17540766INHIBITION OF SARS-CoV-2 VIRUS BY ARUM PALAESTINUMDecember 2021March 2024Abandon2721NoNo
17540810FORMULATIONS INHIBITING SARS-CoV-2 VIRUSDecember 2021April 2024Abandon2821NoNo
17536979COMPOSITIONS AND METHODS FOR INCREASING THE BIOAVAILABILITY OF ONE OR MORE COMPOUNDSNovember 2021February 2025Abandon3810NoNo
17536877COSMETIC COMPOSITION FOR ANTIOXIDANT OR SKIN INFLAMMATION IMPROVEMENT CONTAINING EUPHORBIA SUPINA EXTRACTNovember 2021January 2024Abandon2611NoNo
17526296ANTHOCYANIN POWDER EXTRACT AND PROCESS FOR PRODUCTIONNovember 2021September 2023Allow2210YesNo
17452029HEMP COMPOSITIONS AND METHODS OF MAKING THE SAMEOctober 2021December 2024Abandon3721NoNo
17604841PHARMACEUTICAL COMPOSITION COMPRISING MIXTURE EXTRACT OF COPTIS RHIZOME AND SCHIZONEPETA TENUIFOLIA AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF INFLAMMATORY BOWEL DISEASEOctober 2021October 2024Abandon3501NoNo
17467319Therapeutic Mixture with Oregano Oil for Herpes InfectionsSeptember 2021October 2023Abandon2511NoNo
17466139USE OF HEMOLYMPH OR HEMOLYMPH COMPONENTS TO REGENERATE, REPAIR AND RESTORE THE SKIN BARRIERSeptember 2021June 2025Allow4541NoNo
17460262PHARMACEUTICAL COMPOSITION COMPRISING THE EXTRACT OF CANNABIS SATIVA AS AN EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING OF OBESITYAugust 2021February 2024Abandon3020NoNo
17407004SUPPLEMENT THAT ENHANCES INTRACELLULAR CONCENTRATION OF BIOACTIVE MOLECULES THROUGH INHIBITION OF MULTIDRUG RESISTANT (MDR) EFFLUX PUMPSAugust 2021June 2023Abandon2201NoNo
17406500BUTTER PREPARATION PROCESSAugust 2021February 2025Allow4231YesNo
17401594METHOD AND APPARATUS FOR PRODUCING CANNABIS SMOKE RESINAugust 2021December 2024Abandon4021NoNo
17427380METHODS OF TREATING CANCER USING A COMBINATION OF TUMOR MEMBRANE VESICLES AND METFORMINJuly 2021October 2024Abandon3910NoNo
17421714Anticancer Activity of Buddleja Saligna CompositionsJuly 2021May 2025Allow4621YesNo
17364996PROCESS FOR PRESERVING THE HUSK AND USE OF RAMBUTAN (NEPHELIUM LAPPACEUM) IN FOOD PRODUCTSJuly 2021September 2023Abandon2611NoNo
17365035BITTER GANODERMA LUCIDUM SPORE POWDER AND PREPARATION METHOD THEREOFJuly 2021August 2023Allow2510NoNo
17362707COMPOSITION FOR TREATING VITILIGOJune 2021January 2024Abandon3020YesNo
17358553SYSTEMS AND METHODS FOR PRODUCING A KAVA LIQUID DIETARY SUPPLEMENTJune 2021December 2023Abandon2911NoNo
17353956PROBIOTIC SKIN FORMULATIONSJune 2021May 2024Allow3541YesNo
17416881BIOLOGICALLY ACTIVE SUBSTANCE, METHOD FOR MANUFACTURING SAME AND USE THEREOF AS AN AGENT FOR PROTECTING A BIOLOGICAL TISSUEJune 2021April 2025Allow4531YesNo
17352259Method of Fermenting Soybeans or other Oil Crops by Edible and Medicinal FungiJune 2021May 2025Abandon4721NoNo
17352278COMPOSITIONS OF COFFEE BEAN PRODUCTS, WHOLE HEMP PRODUCTS AND L-THEANINEJune 2021June 2023Abandon2410NoNo
17414595TWO-DOSAGE-FORM ESSENCE AND PREPARATION METHOD THEREOFJune 2021October 2024Allow4011YesNo
17348011SYSTEMS AND METHODS FOR TREATING A DYSBIOSIS USING FECAL-DERIVED BACTERIAL POPULATIONSJune 2021June 2023Abandon2401NoNo
17341064METHODS FOR FAT REDUCTION OR ELIMINATION OF LIPID DROPLETSJune 2021November 2022Allow1801YesNo
17339556Composition for Sterilization of Tree Cutting Devices and a Method of Use ThereofJune 2021April 2024Abandon3421NoNo
17303598Herbal Energy TeaJune 2021May 2023Abandon2301NoNo
17336745THERAPY FOR PROMOTING CELL GROWTHJune 2021February 2025Abandon4540YesNo
17335875CANNABIS PLANT FORMULATIONS AND METHODS OF DELIVERYJune 2021April 2024Abandon3512YesNo
17293825METHODS FOR PREPARING PLATELET RELEASATEMay 2021January 2025Allow4521YesNo
17308459SKINCARE COMPOSITIONS CONTAINING CANNABIDIOLMay 2021January 2024Abandon3221NoNo
17307814BEETROOT-CONTAINING COMPOSITIONMay 2021January 2023Allow2111YesNo
17246698Systems and Methods for Producing a Kava Liquid Dietary SupplementMay 2021November 2023Abandon3011NoNo
17240834NUTRIENT COMPOSITION ABLE TO INHIBIT QUORUM SENSINGApril 2021April 2023Abandon2401NoNo
17301977TOPICAL COSMETIC COMPOSITIONSApril 2021March 2025Abandon4751NoNo
17224554RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONSApril 2021March 2024Abandon3521YesNo
17221437COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY RESPONSEApril 2021May 2023Allow2521YesNo
17221411COMBINED FUNGAL COMPOSITION FOR MODULATING INFLAMMATORY RESPONSEApril 2021May 2023Allow2531NoNo
17217967REPELLANT FORMULATION AND METHODMarch 2021February 2025Allow4631YesYes
17214339POLYPHENOL BLEND OF CURCUMIN EXTRACT AND POMEGRANATE EXTRACT AND METHODS OF IMPROVING IMMUNE RESPONSEMarch 2021June 2025Allow5141YesNo
17210461Pharmaceutical Composition for Promoting Neurogenesis and Method for Promoting Neurogenesis and Inhibiting Senescence of Brain NeuronsMarch 2021April 2025Allow4961NoNo
17194625NERVE GROWTH PROMOTER AND METHOD FOR PRODUCING SAME, INTERNAL PREPARATION, MEDIUM ADDITIVE, CELL DILUTION ADDITIVE, MEDIUM, CELL DILUTION, ANTIOXIDANT AND METHOD FOR PRODUCING SAME, EXTERNAL PREPARATION, AND WOUND TREATMENT AGENT AND METHOD FOR PRODUCING SAMEMarch 2021October 2023Allow3100NoNo
17267086EXTRACELLULAR VESICLES LOADED WITH AN EXOGENOUS MOLECULEFebruary 2021December 2024Abandon4721YesNo
17170735COMPOSITION COMPRISING AN ESSENTIAL OIL AND ITS PACKAGING THEREOFFebruary 2021February 2024Abandon3721NoNo
17264497COSMETIC OR DERMATOLOGICAL COMPOSITIONSJanuary 2021May 2025Abandon5231NoNo
17157139COMPOSITIONS COMPRISING THEANINE, S-ADENOSYLMETHIONINE (SAMe), AND/OR MAGNOLIA AND PHELLODENDRONJanuary 2021February 2023Allow2411YesNo
17126757COMPOSITIONS, METHODS, AND KITS RELATING TO OAK LEAF EXTRACT SUPPRESSION OF CITRUS HUANGLONGBING (HLB) IN CITRUSDecember 2020April 2023Abandon2801NoNo
17123688ENHANCED NON-HORTICULTURE FOOD SUPPLY BIO-SECURITY SYSTEMDecember 2020May 2024Abandon4111YesNo
17121292USE OF HEMOLYMPH OR HEMOLYMPH COMPONENTS FOR THE TREATMENT AND PREVENTION OF INFLAMMATION AND DRY SKINDecember 2020May 2025Allow5341YesNo
15734650WORM PRODUCTS AND METHODS OF USEDecember 2020May 2023Abandon2911NoNo
17059810EXTRACT AND DERMATOLOGICAL COMPOSITION COMPRISING SAME, FOR TREATING SENSITIVE SKINNovember 2020October 2023Allow3431YesNo
17103766WATER-SOLUBLE, FULL-SPECTRUM, CANNABIS COMPLEX AND METHOD OF PRODUCTIONNovember 2020May 2024Abandon4130YesNo
17053362FORMULATIONS COMPRISING NATURAL HYDROSOLS AND USES THEREOFNovember 2020August 2024Abandon4531NoNo
17053040COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING EXTRACTS OF ANEMONE RADDEANA, LONICERA SPECIES, AND ARALIA ELATA CONTAINING HIGH CONCENTRATION OF ANTITUMOR SAPONINS, AND METHOD FOR PREPARING SAMENovember 2020December 2023Allow3831NoNo
17052090HERBAL MEDICINES FOR TREATING POLYCYSTIC KIDNEY DISEASESOctober 2020October 2023Abandon3631YesNo
17049446PREPARATIONS CONTAINING ANTHOCYANINS FOR USE IN THE INFLUENCE OF CARDIOVASCULAR CONDITIONSOctober 2020May 2025Abandon5561NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BOECKELMAN, JACOB A.

Strategic Value of Filing an Appeal

Total Appeal Filings
3
Allowed After Appeal Filing
0
(0.0%)
Not Allowed After Appeal Filing
3
(100.0%)
Filing Benefit Percentile
0.6%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner BOECKELMAN, JACOB A - Prosecution Strategy Guide

Executive Summary

Examiner BOECKELMAN, JACOB A works in Art Unit 1655 and has examined 230 patent applications in our dataset. With an allowance rate of 34.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 33 months.

Allowance Patterns

Examiner BOECKELMAN, JACOB A's allowance rate of 34.8% places them in the 3% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by BOECKELMAN, JACOB A receive 1.95 office actions before reaching final disposition. This places the examiner in the 63% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BOECKELMAN, JACOB A is 33 months. This places the examiner in the 26% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +53.2% benefit to allowance rate for applications examined by BOECKELMAN, JACOB A. This interview benefit is in the 95% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 23.0% of applications are subsequently allowed. This success rate is in the 21% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 18.3% of cases where such amendments are filed. This entry rate is in the 14% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 85% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 95.2% are granted (fully or in part). This grant rate is in the 95% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.